A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients
Not Applicable
- Conditions
- COVID-19 Infection
- Interventions
- Device: Nasal Spray Device
- Registration Number
- NCT04974190
- Lead Sponsor
- The Grasses of Eden Ltd
- Brief Summary
A Nasal Spray device containing Dead Sea minerals and plant extracts, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients
- Detailed Description
A Nasal Spray device containing Dead Sea minerals and plant extracts, designed to incur a PPAR-alpha agonistic effect, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 550
Inclusion Criteria
Having tested positive to Covid-19 on PCR test -
Exclusion Criteria
Pregnancy Low blood pressure On immune system suppressing medications
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Patients treated with actual device with actual solution Nasal Spray Device - Patients treated with actual device with placebo solution Nasal Spray Device -
- Primary Outcome Measures
Name Time Method Symptoms monitoring First 7 days after testing positive on PCR test Monitoring any disease symptoms reported by patient
Covid-19 infection self-testing on days 2, 4 following testing positive on PCR test First 7 days after testing positive on PCR test Testing using a self testing kit of the Quidel QuickView type
- Secondary Outcome Measures
Name Time Method